Treatment with kaempferol causes a downregulation of proliferation in human prostate cancer through suppression of proliferating-cell nuclear antigen (PCNA) and vascular cell adhesion molecule-1 (VCAM-1) [130]. Here, PCNA is linked to prostate carcinoma.